Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection

详细信息    查看全文

• 作者：Elizabeth J. Ryan ; Megan Dring ; Cliona M. Ryan ; Carol McNulty ; Nigel J. Stevenson ; Matthew W. Lawless ; John Crowe ; Niamh Nolan ; John E. Hegarty ; Cliona O'Farrelly
• 关键词：CD209 ; DC-SIGN ; Hepatitis C virus ; Chronic viral infection ; Single-nucleotide polymorphism
• 刊名：Human Immunology
• 出版年：2010
• 出版时间：August 2010
• 年：2010
• 卷：71
• 期：8
• 页码：829-832
• 全文大小：383 K

文摘

CD209, a c-type lectin expressed by dendritic cells (DCs), acts as a pathogen recognition receptor. A single nucleotide polymorphism (SNP) in the promoter region of CD209 (−336 A/G; rs4804803) affects transcription and is associated with the severity of tuberculosis and dengue fever. Because CD209 binds hepatitis C virus (HCV) glycoprotein-E2, we investigated this SNP in the context of chronic HCV infection. A total of 131 Irish women who had received HCV-contaminated anti–D-immunoglobulin and 79 healthy control subjects were genotyped. We found no association between rs4804803 and the risk of HCV chronicity. However, of those with chronic infection, possession of at least one g-allele was associated with more advanced liver disease, with significantly higher liver fibrosis scores and levels of alanine transaminase (ALT) observed. We conclude that rs4804803, an SNP in the CD209 promoter, contributes to severity of liver disease in chronic HCV infection.